Syllabus
BCTXP Prep Course (BCTXP)
79 lessons. Online and self-paced.
Transplant Foundations
Core biology, organ failure states, and transplant process concepts that support medication-related decision-making throughout the exam.
- 1Kidney Failure Pharmacology Context
- 2Liver Failure Pharmacology Context
- 3Cardiopulmonary Failure Pharmacology Context
- 4Pancreas And Multi-Organ Context
- 5Alloimmunity And Histocompatibility
- 6Rejection Phenotypes And Timing
- 7Immunologic Risk Stratification
- 8Desensitization Pharmacotherapy Principles
- 9Candidate Evaluation Medication Issues
- 10Living Donor Medication Considerations
- 11Allocation Scores And Medication Implications
- 12Perioperative Complication Medication Support
Assessment And Planning
Patient assessment framework for pharmacotherapy planning, including PK/PD, diagnostics, pharmacogenomics, vaccines, and special populations.
- 13Medication History And Reconciliation
- 14Laboratory And Diagnostic Interpretation
- 15Allergy And Intolerance Assessment
- 16Calcineurin Inhibitor Pharmacokinetics
- 17Antimetabolite And MTOR Pharmacology
- 18Pharmacogenomics In Transplant Dosing
- 19Special Population PK Considerations
- 20Immunization Planning Across Transplant
- 21Social Determinants And Adherence Risk
- 22Patient Assistance And Access Planning
Immunosuppression Core
Foundational and advanced immunosuppressive therapy selection, implementation, and therapeutic monitoring for transplant recipients.
- 23Lymphocyte-Depleting Induction Agents
- 24IL-2 Receptor Antagonist Use
- 25Induction Selection By Risk
- 26Tacrolimus-Based Triple Therapy
- 27Cyclosporine-Based Regimen Design
- 28MTOR Conversion Strategies
- 29Belatacept And CNI Avoidance
- 30Tacrolimus Trough Interpretation
- 31Cyclosporine Concentration Monitoring
- 32MTOR Level And Toxicity Monitoring
Interactions And Toxicity
Drug interactions, formulation issues, and immunosuppressant toxicities frequently tested in transplant pharmacy scenarios.
- 33Azole And Macrolide Interactions
- 34Inducers And Subtherapeutic Exposure
- 35Food Formulation And Route Effects
- 36Complex Interaction Case Patterns
- 37CNI Nephrotoxicity And Neurotoxicity
- 38Antimetabolite GI And Marrow Toxicity
- 39MTOR Toxicity Syndromes
- 40Steroid Complication Mitigation
- 41Enteral And Feeding Tube Administration
- 42IV To Oral Conversion
- 43Adherence Packaging And Simplification
Infection Prevention
Transplant infectious prophylaxis, immunization timing, and early antimicrobial decision support within pharmacist scope.
- 44CMV Risk Stratification
- 45CMV Prophylaxis And Treatment Support
- 46BK And EBV Medication Implications
- 47PJP Prophylaxis Selection
- 48Antifungal Prophylaxis Strategies
- 49Opportunistic Infection Drug Traps
- 50Perioperative Antibacterial Prophylaxis
- 51Recipient Vaccine Counseling
- 52Post-Exposure Pharmacotherapy Planning
Rejection And Graft Dysfunction
Medication-related evaluation and management support for rejection, underimmunosuppression, and common causes of graft dysfunction.
- 53Cellular Rejection Treatment Support
- 54Antibody-Mediated Rejection Support
- 55Rejection Versus Drug Toxicity
- 56Chronic Allograft Injury Signals
- 57Nonadherence And Variable Exposure
- 58Protocol Variability And Safe Answers
- 59Kidney Graft Dysfunction Workup
- 60Liver Heart Lung Dysfunction Clues
- 61Pancreas And Multi-Organ Dysfunction
Organ-Specific Management
High-yield transplant pharmacotherapy distinctions across major organ programs and post-transplant comorbidities.
- 62Delayed Graft Function Support
- 63Recurrent Kidney Disease Medication Issues
- 64Pancreas Glycemic And Enzyme Monitoring
- 65Liver Transplant Drug Challenges
- 66Heart Transplant Vasculopathy Prevention
- 67Lung Transplant Infection Balance
- 68Hypertension Dyslipidemia And ASCVD
- 69Post-Transplant Diabetes Management
- 70Bone Health And Malignancy Prevention
Professional Practice
Quality, safety, regulations, ethics, insurance, research, and team-based practice through a transplant pharmacist lens.
- 71Guideline-Informed Transplant Decisions
- 72Medication Safety In Transitions
- 73Interprofessional Escalation And Scope
- 74Ethics And Patient Advocacy
- 75Insurance Formularies And Appeals
- 76Collaborative Practice And Documentation
- 77Trial Design And Endpoint Appraisal
- 78Biostatistics For Board Questions
- 79Education Of Learners And Patients






